Motus GI (NASDAQ:MOTS) vs. Autonomix Medical (NASDAQ:AMIX) Critical Comparison

Autonomix Medical (NASDAQ:AMIX) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, analyst recommendations, dividends, earnings and profitability.

Analyst Ratings

This is a summary of current ratings and recommmendations for Autonomix Medical and Motus GI, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	0	0	0	0	N/A
Motus GI	0	0	1	0	3.00

Motus GI has a consensus price target of $28.88, indicating a potential upside of 41,150.00%. Given Motus GI’s higher possible upside, analysts plainly believe Motus GI is more favorable than Autonomix Medical.

Earnings & Valuation

This table compares Autonomix Medical and Motus GI’s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$15.43 million	N/A	N/A
Motus GI	$320,000.00	1.26	-$12.87 million	($15.64)	0.00

Motus GI has higher revenue and earnings than Autonomix Medical.

Institutional and Insider Ownership

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 20.1% of Motus GI shares are held by institutional investors. 0.3% of Motus GI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Autonomix Medical and Motus GI’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	N/A	N/A
Motus GI	-3,239.75%	-1,731.08%	-115.99%

Summary

Motus GI beats Autonomix Medical on 6 of the 9 factors compared between the two stocks.

About Autonomix Medical

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

About Motus GI

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.